feed,title,long_url,short_url
Preprints,"Immunogenicity of the Monovalent Omicron XBB.1.5-Adapted BNT162b2 COVID-19 Vaccine Against XBB.1.5, BA.2.86, and JN.1 Sublineages: A Phase 2/3 Trial",https://www.preprints.org/manuscript/202404.1119/v1,https://da.gd/wEzSAK
